Douglas V Faller - 02 Jan 2026 Form 4 Insider Report for Imunon, Inc. (IMNN)

Role
Chief Medical Officer
Signature
/s/ Susan Eylward, Attorney-in-Fact for Douglas V. Faller
Issuer symbol
IMNN
Transactions as of
02 Jan 2026
Net transactions value
$0
Form type
4
Filing time
06 Jan 2026, 16:08:16 UTC
Previous filing
19 Feb 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Faller Douglas Vincent Chief Medical Officer C/O IMUNON, INC., 997 LENOX DRIVE, SUITE 100, LAWRENCEVILLE /s/ Susan Eylward, Attorney-in-Fact for Douglas V. Faller 06 Jan 2026 0002056033

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMNN Stock Option (Right to Buy) Award $0 +12,667 $0.000000 12,667 02 Jan 2026 Common Stock 12,667 $3.95 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the closing price of Imunon, Inc. Common Stock on the date of the grant
F2 The options vest as follows: 1/2 on the date of grant; 1/4 on the one year anniversary of the date of grant; and 1/4 on the second year anniversary of the date of grant.